Annals of the Academy of Medicine, Singapore · 2016
Guidelines for the Management of Atopic Dermatitis in Singapore.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tay Yong Kwang, Chan Yuin Chew, Chandran Nisha Suyien, Ho Madeline Sl, Koh Mark Ja, Lim Yen Loo, Tang Mark By, Thirumoorthy Thamotharampillai
Аннотация
INTRODUCTION: Atopic dermatitis is a common, chronic pruritic condition affecting both children and adults, which has a negative impact on the quality of life. These guidelines were developed by an expert workgroup appointed by the Dermatological Society of Singapore, to provide doctors with information to assist in the management of their patients with atopic dermatitis. The workgroup members are experienced dermatologists with interest and expertise in eczemas.
MATERIALS AND METHODS: Workgroup members arrived at a consensus on the topics to be included. Relevant studies from the literature were assessed for best evidence, supplemented by the collective experience of the workgroup.
RESULTS: For mild atopic dermatitis, emollients, mild potency topical steroids and topical calcineurin inhibitors are recommended. For moderate-to-severe atopic dermatitis, the use of emollients, moderate-to-potent topical steroids, topical calcineurin inhibitors, wet dressings, antimicrobials for secondary skin infection, phototherapy, and systemic therapy (e.g. prednisolone, cyclosporine, azathioprine or methotrexate) may be warranted. Patients with moderate-to-severe atopic dermatitis should be managed in conjunction with a dermatologist.
CONCLUSION: Good outcomes can be achieved with an individualised therapeutic approach combined with adequate patient and parental education.
MATERIALS AND METHODS: Workgroup members arrived at a consensus on the topics to be included. Relevant studies from the literature were assessed for best evidence, supplemented by the collective experience of the workgroup.
RESULTS: For mild atopic dermatitis, emollients, mild potency topical steroids and topical calcineurin inhibitors are recommended. For moderate-to-severe atopic dermatitis, the use of emollients, moderate-to-potent topical steroids, topical calcineurin inhibitors, wet dressings, antimicrobials for secondary skin infection, phototherapy, and systemic therapy (e.g. prednisolone, cyclosporine, azathioprine or methotrexate) may be warranted. Patients with moderate-to-severe atopic dermatitis should be managed in conjunction with a dermatologist.
CONCLUSION: Good outcomes can be achieved with an individualised therapeutic approach combined with adequate patient and parental education.
Предметные рубрики MeSH
Administration, CutaneousAdrenal Cortex HormonesAnti-Bacterial AgentsAzathioprineCalcineurin InhibitorsCoinfectionCyclosporineDermatitis, AtopicDermatologyDisease ManagementEmollientsFood HypersensitivityHumansImmunosuppressive AgentsMethotrexatePatient Education as TopicPhototherapyPractice Guidelines as TopicReferral and ConsultationSeverity of Illness IndexSingapore